Ian MacLachlan
51Patents
28h-index
34Co-inventors
88Inventor score
Filing activity: Feb 2, 1999 → Jan 12, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8569256B2 | Cationic lipids and methods for the delivery of therapeutic agents | Chemistry; Metallurgy | 331 | Active |
| US8058069B2 | Lipid formulations for nucleic acid delivery | Chemistry; Metallurgy | 283 | Active |
| US7745651B2 | Cationic lipids and methods of use | Human Necessities | 228 | Active |
| US7799565B2 | Lipid encapsulated interfering RNA | Chemistry; Metallurgy | 228 | Expired |
| US7901708B2 | Liposomal apparatus and manufacturing methods | Human Necessities | 216 | Active |
| US7803397B2 | Polyethyleneglycol-modified lipid compounds and uses thereof | Chemistry; Metallurgy | 190 | Expired |
| US8329070B2 | Liposomal apparatus and manufacturing method | Human Necessities | 141 | Active |
| US9364435B2 | Lipid formulations for nucleic acid delivery | Chemistry; Metallurgy | 141 | Active |
| US8101741B2 | Modified siRNA molecules and uses thereof | Chemistry; Metallurgy | 140 | Active |
| US8188263B2 | Modified siRNA molecules and uses thereof | Chemistry; Metallurgy | 132 | Active |
| US8236943B2 | Compositions and methods for silencing apolipoprotein B | Emerging Cross-Sectional Technologies | 128 | Active |
| US9504651B2 | Lipid compositions for nucleic acid delivery | Human Necessities | 122 | Active |
| US7982027B2 | Lipid encapsulated interfering RNA | Human Necessities | 115 | Active |
| US8513403B2 | Modified siRNA molecules and uses thereof | Chemistry; Metallurgy | 103 | Active |
| US8999950B2 | Compositions and methods for silencing aldehyde dehydrogenase | Chemistry; Metallurgy | 98 | Active |
| US9018187B2 | Cationic lipids and methods for the delivery of therapeutic agents | Emerging Cross-Sectional Technologies | 97 | Active |
| US8283333B2 | Lipid formulations for nucleic acid delivery | Emerging Cross-Sectional Technologies | 94 | Active |
| US8936942B2 | Polyethyleneglycol-modified lipid compounds and uses thereof | Chemistry; Metallurgy | 92 | Active |
| US9074208B2 | Modified siRNA molecules and uses thereof | Chemistry; Metallurgy | 88 | Active |
| US9187748B2 | Compositions and methods for silencing ebola virus gene expression | Chemistry; Metallurgy | 87 | Active |
| US8822668B2 | Lipid formulations for nucleic acid delivery | Chemistry; Metallurgy | 72 | Active |
| US7838658B2 | siRNA silencing of filovirus gene expression | Chemistry; Metallurgy | 66 | Active |
| US9428751B2 | Compositions and methods for silencing apolipoprotein C-III expression | Chemistry; Metallurgy | 64 | Active |
| US9492386B2 | Liposomal apparatus and manufacturing methods | Human Necessities | 60 | Active |
| US7807815B2 | Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA | Chemistry; Metallurgy | 58 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.